March 25, 2019 – NIH Division of AIDS (DAIDS), ABL Inc, Ufovax Inc and Dr. Zhu (on behalf of Scripps Research) held a kickoff meeting to start the cGMP process development for the HIV-1 nanoparticle vaccines developed in Dr. Zhu’s laboratory.
March 25, 2019 – NIH Division of AIDS (DAIDS), ABL Inc, Ufovax Inc and Dr. Zhu (on behalf of Scripps Research) held a kickoff meeting to start the cGMP process development for the HIV-1 nanoparticle vaccines developed in Dr. Zhu’s laboratory.